Lack of correlation between Ki-67 labelling index and tumor size of anterior pituitary adenomas
- PMID: 11570981
- PMCID: PMC56633
- DOI: 10.1186/1471-2407-1-12
Lack of correlation between Ki-67 labelling index and tumor size of anterior pituitary adenomas
Abstract
Aims and background: The Ki-67 is a nuclear antigen detected by the monoclonal antibody MIB-1 and its Labeling Index (LI) is considered a marker of normal and abnormal cell proliferation. Pituitary adenomas are generally well differentiated neoplasms, even if in about one third of cases they are invasive of surrounding tissues. The aim of this study is to evaluate the correlation between Ki-67 labelling index and tumor size of pituitary adenomas extimated by means CT and MRI and confirmed at operation.
Methods: Using the monoclonal antibody MIB-1, we evaluated the expression of Ki-67 in 121 anterior pituitary adenomas consecutively operated on in a 48-month period.
Results: In relation to neuroradiological (CT and MRI) and surgically verified tumor size, we identified 24 microadenomas, 27 intrasellar macroadenomas, 34 intra-suprasellar macroadenomas, and 36 intra-supra-parasellar macroadenomas. The adenomas were non-infiltrating (76 cases) and infiltrating (45 cases) adenomas. The wall of the cavernous sinus (CS) was infiltrated in 18 cases. Forty-eight adenomas were non-functioning and 73 functioning. The overall mean +/- SD Ki-67 LI was 2.72 +/- 2.49% (median 1.6). It was 2.59 +/- 1.81 in microadenomas, 2.63 +/- 3.45 in intrasellar macroadenomas, 1.91 +/- 2.11 in intra-suprasellar macroadenomas, and 3.29 +/- 5.45 in intra-supra-parasellar macroadenomas (p = 0.27). It was 3.73 +/- 5.13% in infiltrating and 2.03 +/- 2.41% in non-infiltrating adenomas (p = 0.02), and 5.61 +/- 7.19% in CS-infiltrating versus 2.09 +/- 2.37% in CS-non-infiltrating adenomas (p = 0.0005).
Conclusions: Our preliminary results seem to exclude significative correlations between Ki-67 LI and tumor size of anterior pituitary adenomas, even if this index can be considered a useful marker in the determination of the infiltrative behaviour of these tumors.
Figures
Similar articles
-
Ki-67 labelling index and invasiveness among anterior pituitary adenomas: analysis of 103 cases using the MIB-1 monoclonal antibody.J Clin Pathol. 1999 Feb;52(2):107-11. doi: 10.1136/jcp.52.2.107. J Clin Pathol. 1999. PMID: 10396237 Free PMC article.
-
Adrenocorticotropic hormone secreting pituitary adenomas: analysis of growth fraction using the MIB-1 antibody.Tumori. 2000 May-Jun;86(3):229-32. doi: 10.1177/030089160008600310. Tumori. 2000. PMID: 10939604
-
Cell proliferation parameters and apoptosis indices in pituitary macroadenomas.J Endocrinol Invest. 2012 May;35(5):473-8. doi: 10.3275/7905. Epub 2011 Sep 6. J Endocrinol Invest. 2012. PMID: 21897111
-
Labeling index in pituitary adenomas evaluated by means of MIB-1: is there a prognostic role? A critical review.Neurol Res. 2010 Dec;32(10):1060-71. doi: 10.1179/016164110X12670144737855. Epub 2010 May 18. Neurol Res. 2010. PMID: 20483025 Review.
-
Predictive markers of pituitary adenoma behavior.Neuroendocrinology. 2006;83(3-4):179-88. doi: 10.1159/000095526. Epub 2006 Oct 13. Neuroendocrinology. 2006. PMID: 17047381 Review.
Cited by
-
Determination of cell proliferation using Mcm2 antigen and evaluation of apoptosis and TGF-beta1 expression in GH-secreting or clinically nonfunctioning pituitary adenomas.Endocr Pathol. 2010 Mar;21(1):32-9. doi: 10.1007/s12022-010-9107-x. Endocr Pathol. 2010. PMID: 20174894
-
Pituitary carcinoma diagnosed on fine needle aspiration: Report of a case and review of pathogenesis.Cytojournal. 2010 Aug 5;7:14. doi: 10.4103/1742-6413.67108. Cytojournal. 2010. PMID: 20806088 Free PMC article.
-
Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review.Pituitary. 2014 Jun;17(3):267-76. doi: 10.1007/s11102-013-0500-6. Pituitary. 2014. PMID: 23828322 Review.
-
A Nomogram for Preoperatively Predicting the Ki-67 Index of a Pituitary Tumor: A Retrospective Cohort Study.Front Oncol. 2021 May 31;11:687333. doi: 10.3389/fonc.2021.687333. eCollection 2021. Front Oncol. 2021. PMID: 34136412 Free PMC article.
-
Evaluation of the potential of the Ki67 index to predict tumor evolution in patients with pituitary adenoma.Int J Clin Exp Pathol. 2019 Jan 1;12(1):320-326. eCollection 2019. Int J Clin Exp Pathol. 2019. PMID: 31933748 Free PMC article.
References
-
- Asano K, Kubo O, Tajika Y, Huang MC, Takakura K. The relationship between cell proliferation and secretory activity in pituitary adenomas. A review of 63 cases. No To Shinkei. 1996;48:543–549. - PubMed
-
- Atkin SL, Green VL, Hipkin LJ, Landolt AM, Foy PM, Jeffreys RV, et al. A comparison of proliferation indices in human anterior pituitary adenomas using formalin-fixed tissue and in vitro cell culture. J Neurosurg. 1997;87:85–88. - PubMed
-
- Brown DC, Gatter KC. Monoclonal antibody Ki-67: its use in histopathology. Histopathology. 1990;17:489–503. - PubMed
-
- Buchfelder M, Fahlbusch R, Adams EF, Kiesewetter F, Thierauf P. Proliferation parameters for pituitary adenomas. Acta Neurochir Suppl (Wien) 1996;65:18–21. - PubMed
-
- Daita G, Yonemasu Y. Dural invasion and proliferative potential of pituitary adenomas. Neurol Med Chir. 1996;36:211–214. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases